Literature DB >> 206677

Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.

C B Hall, R G Douglas, R L Simons, J M Geiman.   

Abstract

To better understand the recovery process of infants with lower respiratory tract disease due to respiratory syncytial virus, the production of interferon by 129 children (ages 10 days to 24 months) with RSV infection was compared to that of 20 children with influenza (ages 1 to 36 months), and 37 children with parainfluenza virus infection (ages 4 to 66 months). Interferon assays of 285 nasal washes from children with RSV revealed that interferon production occurred in only 5 (4%) of the children. Significantly more children infected with infleunza virus, 55% (P less than 0.001), and parainfluenza virus, 30% (P less than 0.001), produced interferon. In addition, the quantity of interferon produced by children with RSV (geometric mean titer = 2) was significantly less than that of children with influenza (GMT = 26.8, P less than 0.001) and parainfluenza virus (GMT = 23.5, P less than 0.001). In the children infected with RSV, in constrast to those with influenza, interferon detection was not associated with diminished shedding of virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206677     DOI: 10.1016/s0022-3476(78)80594-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  59 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Cold comfort for the catarrhal child.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

3.  Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Authors:  Luis Martinez-Sobrido; Negin Gitiban; Ana Fernandez-Sesma; Jerome Cros; Sara E Mertz; Nancy A Jewell; Sue Hammond; Emilio Flano; Russell K Durbin; Adolfo García-Sastre; Joan E Durbin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 4.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 5.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

6.  Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon.

Authors:  J Gao; B P De; Y Han; S Choudhary; R Ransohoff; A K Banerjee
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.

Authors:  J R Panuska; R Merolla; N A Rebert; S P Hoffmann; P Tsivitse; N M Cirino; R H Silverman; J A Rankin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.

Authors:  J Portnoy; R Hicks; F Pacheco; L Olson
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

9.  Secretory immunological response in infants and children to parainfluenza virus types 1 and 2.

Authors:  R Yanagihara; K McIntosh
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

10.  Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.

Authors:  T N Kaul; R C Welliver; P L Ogra
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.